检索结果 - Linnea Chap

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Targeting Signal Transduction Pathways in Metastatic Breast Cancer: A Comprehensive Review

    Targeting Signal Transduction Pathways in Metastatic Breast Cancer: A Comprehensive Review 由 Lee S. Rosen, Helen Louise Ashurst, Linnea Chap

    出版 2010
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    A Phase I Dose-Escalation Trial of Trastuzumab and Alvespimycin Hydrochloride (KOS-1022; 17 DMAG) in the Treatment of Advanced Solid Tumors

    A Phase I Dose-Escalation Trial of Trastuzumab and Alvespimycin Hydrochloride (KOS-1022; 17 DMAG) in the Treatment of Advanced Solid Tumors 由 Komal Jhaveri, Kathy D. Miller, Lee S. Rosen, Bryan P. Schneider, Linnea Chap, Alison L. Hannah, Ziyang Zhong, Weining Ma, Clifford A. Hudis, Shanu Modi

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Peripheral Blood Progenitor Cell Mobilization Using Stem Cell Factor in Combination With Filgrastim in Breast Cancer Patients

    Peripheral Blood Progenitor Cell Mobilization Using Stem Cell Factor in Combination With Filgrastim in Breast Cancer Patients 由 John A. Glaspy, Elizabeth J. Shpall, C.F. LeMaistre, Robert Briddell, Dora Menchaca, Stewart A. Turner, Michael Lill, Linnea Chap, Rena R. Jones, M.D. Wiers, William Sheridan, IK McNiece

    出版 1997
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer

    Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer 由 Kathy D. Miller, Linnea Chap, Frankie A. Holmes, Melody A. Cobleigh, P. Kelly Marcom, Louis Fehrenbacher, Maura N. Dickler, Beth Overmoyer, James D. Reimann, Amy P. Sing, Virginia K. Langmuir, Hope S. Rugo

    出版 2005
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib

    Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib 由 R. Charles Coombes, Sacha J. Howell, Simon Lord, Laura Kenny, Janine Mansi, Zahi Mitri, Carlo Palmieri, Linnea Chap, Paul Richards, William J. Gradishar, Sagar Sardesai, Jason Melear, Joyce O’Shaughnessy, Patrick J. Ward, Pavani Chalasani, Hendrik‐Tobias Arkenau, Richard D. Baird, Rinath Jeselsohn, Simak Ali, Glen Clack, Ashwani Bahl, Stuart McIntosh, Matthew Krebs

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Adjuvant Docetaxel for Node-Positive Breast Cancer

    Adjuvant Docetaxel for Node-Positive Breast Cancer 由 Miguel Martín, Tadeusz Pieńkowski, John R. Mackey, Marek Pawlicki, Jean‐Paul Guastalla, Charles H. Weaver, Eva Tomiak, Taher Al‐Tweigeri, Linnea Chap, É Juhos, R. Guévin, Anthony Howell, Tommy� Fornander, John D. Hainsworth, Robert E. Coleman, J. Vinholes, Manuel Modiano, Tamás Pintér, Shou Ching Tang, Bruce Colwell, Catherine Prady, Louise Provencher, David Walde, Álvaro Rodríguez-Lescure, Judith Hugh, Camille Loret, Matthieu Rupin, Sandra Blitz, Philip Jacobs, M Murawsky, A. Riva, Charles L. Vogel

    出版 2005
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: